RadNetRDNT
RDNT
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
152% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 21
8% more funds holding
Funds holding: 298 [Q3] → 322 (+24) [Q4]
1.37% more ownership
Funds ownership: 84.9% [Q3] → 86.27% (+1.37%) [Q4]
5% more call options, than puts
Call options by funds: $7.22M | Put options by funds: $6.9M
2% more capital invested
Capital invested by funds: $4.36B [Q3] → $4.46B (+$103M) [Q4]
3% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 116
18% less funds holding in top 10
Funds holding in top 10: 11 [Q3] → 9 (-2) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$60
19%
upside
Avg. target
$73
45%
upside
High target
$88
74%
upside
4 analyst ratings
4 positive
100%
0 neutral
0%
0 negative
0%
Barclays Andrew Mok 41% 1-year accuracy 24 / 58 met price target | 19%upside $60 | Overweight Maintained | 24 Mar 2025 |
Raymond James John Ransom 33% 1-year accuracy 3 / 9 met price target | 28%upside $65 | Strong Buy Upgraded | 5 Mar 2025 |
Truist Securities David Macdonald 62% 1-year accuracy 58 / 93 met price target | 74%upside $88 | Buy Reiterated | 22 Jan 2025 |
Jefferies Brian Tanquilut 44% 1-year accuracy 4 / 9 met price target | 58%upside $80 | Buy Maintained | 15 Jan 2025 |
Financial journalist opinion
Positive
Benzinga
2 weeks ago
Top 3 Health Care Stocks You'll Regret Missing This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Neutral
GlobeNewsWire
2 weeks ago
RadNet, Inc. to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference March 17th, 2025
LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Executive Officer, will be presenting virtually at the 35th Oppenheimer Healthcare MedTech & Services Conference on Monday, March 17, 2025 at 12:40 p.m. Eastern Time.
Neutral
Seeking Alpha
1 month ago
RadNet, Inc. (RDNT) Q4 2024 Earnings Call Transcript
RadNet, Inc. (NASDAQ:RDNT ) Q4 2024 Earnings Conference Call February 28, 2025 10:30 AM ET Company Participants Mark Stolper - Executive Vice President & Chief Financial Officer Howard Berger - President & Chief Executive Officer Conference Call Participants David MacDonald - Truist Brian Tanquilut - Jefferies John Ransom - Raymond James Andrew Mok - Barclays Larry Solow - CJS Securities Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the RadNet, Inc. Fourth Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode.
Positive
Zacks Investment Research
1 month ago
RadNet (RDNT) Tops Q4 Earnings and Revenue Estimates
RadNet (RDNT) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.20 per share a year ago.
Neutral
GlobeNewsWire
1 month ago
RadNet Reports Fourth Quarter 2024 Results, Including Record Revenue and Adjusted EBITDA(1) and Releases 2025 Financial Guidance
LOS ANGELES, Feb. 27, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 398 owned and/or operated outpatient imaging centers, today reported financial results for its fourth quarter and full-year ended December 31, 2024.
Neutral
GlobeNewsWire
1 month ago
RadNet and OB/GYN Specialists of the Palm Beaches Enhance Breast Cancer Screening with State-of-the-Art Imaging Services
South Florida's largest OB/GYN provider innovates with AI-powered breast screening. South Florida's largest OB/GYN provider innovates with AI-powered breast screening.
Neutral
GlobeNewsWire
1 month ago
DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at #ECR2025
VIENNA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), will introduce next-generation AI-powered radiology informatics and population screening solutions at the European Congress of Radiology (ECR) 2025 in Vienna. With the aim of empowering breakthroughs in care enabled by imaging, DeepHealth's suite of solutions addresses critical clinical and operational challenges experienced by healthcare providers around the world. DeepHealth's solutions are powered by DeepHealth OS, a secure, scalable, and cloud-native operating system that integrates data across various solutions and enables interoperability with broader healthcare IT ecosystems. Moreover, to enable AI adoption at scale, DeepHealth has established strategic collaborations enabling integrated solutions with ecosystem industry leaders.
Neutral
GlobeNewsWire
1 month ago
RadNet's Wholly-Owned Subsidiary, DeepHealth, and ConcertAI's TeraRecon Announce Strategic Collaboration Around Integrated AI and Advanced Visualization
LOS ANGELES and SOMERVILLE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT) and ConcertAI's TeraRecon, a leader in medical imaging advanced visualization, clinical AI, and workflow automation, announced today a strategic collaboration to integrate certain capabilities to advance imaging tools and the radiology workflow. This collaboration is first designed to create a seamless AI-enabled diagnostic experience for radiologists and imaging specialists through integrating TeraRecon's advanced visualization (AV) technology into DeepHealth OS cloud-native Operating System. Additionally, the collaboration seeks to incorporate DeepHealth's clinical AI solutions into TeraRecon's AI ecosystem, enabling physicians to deliver precise and timely diagnostic interpretations.
Negative
Zacks Investment Research
1 month ago
Analysts Estimate RadNet (RDNT) to Report a Decline in Earnings: What to Look Out for
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
GlobeNewsWire
1 month ago
RadNet, Inc. Announces Date of its Fourth Quarter 2024 Financial Results Conference Call
LOS ANGELES, Feb. 14, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its fourth quarter 2024 financial results on Friday, February 28, 2024 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Charts implemented using Lightweight Charts™